Omepril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Omepril

Quick Facts

Property Description
Active ingredient Omeprazole
Form Delayed-release capsules, oral suspension, intravenous formulation
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Profoundly reduces gastric acid secretion
Origin Synthetic compound (benzimidazole derivative)

What is Omepril and What Type of Drug is it?

The drug Omepril contains the single active substance Omeprazole, which is a synthetic compound chemically classified as a benzimidazole derivative. This classification confirms its chemical structure is man-made, not naturally derived. Omeprazole belongs to the Proton Pump Inhibitor (PPI) pharmacological class, which represents a category of medicines used to decrease the amount of acid the stomach produces. The efficacy of the PPI class in acid control is widely supported by decades of pharmacological studies and is recognized globally as the standard for potent acid suppression.

As the first clinically useful drug in the PPI class, Omeprazole established the foundational mechanism for subsequent similar compounds. It functions by achieving the irreversible inhibition of the final step of acid secretion within the stomach's parietal cells. This precise action on the acid-secreting enzyme, the proton pump, establishes its identity as a potent agent designed for profound acid control.

Omeprazole's Identity: Forms, Composition, and General Purpose

Omeprazole is typically supplied for oral administration in delayed-release capsules containing enteric-coated pellets, though a sterile intravenous formulation is available for clinical use when oral intake is not possible. The single-ingredient product is engineered such that the protective coating ensures the active component is not destroyed by stomach acid before being absorbed.

The drug's primary therapeutic objective is to suppress acid production. By significantly minimizing the concentration of acid in the gastrointestinal tract, Omeprazole provides the general benefit of relieving acid-related discomfort and facilitates the natural healing process of irritated tissues in the upper digestive system. This medication is used to control severe acid output in the stomach.

Regulatory References

  1. Omeprazole Drug Information, MedlinePlus

What side effects are possible with Omepril?

Possible Side Effects and Safety Information

The safety profile for Omeprazole, the active ingredient in Omepril, is documented through official government regulatory classifications. Adverse reactions are grouped by their documented frequency and the physiological systems affected, providing a structured understanding of the medicine's risk characteristics.

Frequency-Classified Adverse Reactions

The most commonly documented adverse reactions, classified as Common in regulatory labels, include headache and various gastrointestinal effects such as abdominal pain, diarrhea, nausea/vomiting, and flatulence. Less frequent effects, classified as Uncommon, may include insomnia, dizziness, and elevated liver enzymes.

Serious Adverse Reactions and Long-Term Safety

Official prescribing information notes the potential for rare, but clinically serious, adverse reactions. These include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome, and inflammation of the kidneys known as Acute Tubulointerstitial Nephritis.

Regulatory documents highlight risks associated with prolonged use. These duration-related patterns include an increased risk of bone fracture (hip, wrist, or spine), the potential for Cyanocobalamin (Vitamin B-12) deficiency, and hypomagnesemia (low magnesium). The drug's symptomatic relief does not rule out the presence of an underlying gastric malignancy, a safety constraint noted in official labeling.

Population-Specific Notes

The official safety information notes that the metabolism of Omeprazole may be somewhat slower in the elderly. Increased systemic exposure is also documented in Asian patients.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents describe the Omeprazole overdose profile through specific documented manifestations and mandatory emergency actions. While overdose is typically associated with transient symptoms, certain severe manifestations require immediate attention. The treatment approach is entirely supportive, as no specific reversing agent is known.

Overdose Manifestations Mandatory Emergency Actions
Gastrointestinal Effects: Nausea, vomiting, diarrhea, abdominal pain, and flatulence. Seek Emergency Medical Attention for any suspected overdose exposure, contacting the Poison Help line or a hospital emergency department immediately.
CNS/Systemic Effects: Headache, confusion, drowsiness, blurred vision, dryness of the mouth, flushing, and increased sweating. Contact emergency services (e.g., 911) immediately if the individual exhibits severe, life-threatening signs.

Severe Symptom Triggers Immediate emergency services must be contacted when the exposed individual shows signs such as collapse, a seizure (convulsion), or trouble breathing. The officially documented management plan involves providing symptomatic and supportive treatment and continuous clinical monitoring, given the regulatory statement that no specific antidote is known for Omeprazole.

Therapeutic Uses of Omepril

What Omepril treats: main uses and benefits

Omepril is a medication belonging to the class of proton pump inhibitors (PPIs). Its primary function is to reduce the amount of acid produced in the stomach, which helps manage conditions where excess gastric acid causes discomfort or damage to the digestive tract.

Acid-Related Gastric Conditions

Omepril is frequently used to treat several conditions involving the stomach and esophagus:

  • Gastroesophageal Reflux Disease (GERD): This condition occurs when stomach acid flows back into the esophagus, causing symptoms such as heartburn and acid regurgitation. Omepril helps alleviate these symptoms and allows the esophageal lining to heal if it has been damaged.
  • Gastric and Duodenal Ulcers: The medication is used to treat active ulcers in the stomach or the upper part of the small intestine (the duodenum). By reducing acid, it provides an environment conducive to the healing of the ulcerated tissue.
  • Erosive Esophagitis: For individuals whose esophagus has become inflamed or eroded due to chronic acid exposure, Omepril is used to promote healing and provide relief from associated pain.

Combination Therapy and Long-term Management

In certain clinical scenarios, Omepril serves as a component of a broader treatment plan:

  • Helicobacter pylori Eradication: In patients with ulcers caused by H. pylori bacteria, Omepril is often used alongside antibiotics. The reduction in acid increases the effectiveness of the antibiotics and helps the ulcer heal.
  • NSAID-Associated Ulcer Prevention: For patients who require long-term treatment with non-steroidal anti-inflammatory drugs (NSAIDs), Omepril may be used to reduce the risk of developing stomach ulcers associated with these medications.
  • Hypersecretory Conditions: Omepril is used to manage rare conditions characterized by the pathological overproduction of stomach acid, such as Zollinger-Ellison syndrome.

Expected Benefits

The therapeutic goal of Omepril is to restore balance to the digestive environment. Benefits typically include the reduction of chronic heartburn, the resolution of abdominal pain related to acidity, and the prevention of complications such as esophageal strictures or bleeding ulcers. By maintaining lower acid levels, the medication supports the long-term integrity of the gastrointestinal mucosa.

Regulatory References

  1. European Medicines Agency (EMA) Summary of Product Characteristics

Eligibility and Restrictions for Use

Omeprazole (often sold under the brand name Omepril) is generally suitable for use by most adults and, with prescription and supervision, by children and infants for appropriate conditions. It is used to treat acid-related disorders like GERD, ulcers, and Zollinger-Ellison syndrome.


Who Can and Cannot Use Omeprazole

Population Group General Guidance
Most Adults Generally suitable for short-term and long-term use as prescribed.
Children/Infants Safe when prescribed and dosed based on age and weight for specific conditions like GERD.
Pregnant/Breastfeeding Use is generally considered acceptable, but always consult a healthcare provider to weigh benefits and risks.
Elderly Patients Can be used, though older adults may be more sensitive to the medication and may require monitoring.

Omeprazole is contraindicated (should not be used) if you have:

  • A known allergy or serious hypersensitivity to omeprazole or any other proton pump inhibitor (PPI).
  • Are taking certain antiretroviral drugs (e.g., rilpivirine, nelfinavir) used to treat HIV, as omeprazole can significantly reduce their effectiveness.

Use with caution and medical supervision is required for individuals with:

  • Severe liver disease (dosage adjustments may be needed).
  • A history of systemic lupus erythematosus (SLE), osteoporosis (long-term use increases fracture risk), or low magnesium levels (hypomagnesemia).

What should I know about interactions with other medicines?

Omepril Interactions with other medicines and products

Omeprazole can interact with a wide range of medicinal products primarily through two key mechanisms that affect how other drugs work in the body.

Impact on Other Medicines

Omeprazole is a known inhibitor of the Cytochrome P450 enzyme CYP2C19 and, to a lesser extent, CYP3A4. This inhibition can lead to increased systemic exposure of co-administered drugs that are metabolized by these enzymes. Products affected include:

  • Anticoagulants (e.g., Warfarin)
  • Anticonvulsants (e.g., Phenytoin)
  • Cilostazol (requiring dose reduction)
  • Diazepam

Furthermore, omeprazole significantly reduces gastric acid, which can affect the absorption of medicines whose bioavailability depends on an acidic environment. These include antifungals (e.g., Ketoconazole), iron salts, and ampicillin esters. Conversely, this reduction in acid can increase the absorption of Digoxin.

Drug Combinations to Avoid

Specific drug combinations are constrained in official guidance due to safety or efficacy concerns:

  • Clopidogrel: Concomitant use is generally discouraged as omeprazole can diminish the antiplatelet activity of clopidogrel by inhibiting its activation pathway (CYP2C19).
  • HIV Protease Inhibitors (e.g., Atazanavir, Nelfinavir): Co-administration is not recommended as omeprazole can substantially reduce the plasma levels of these antivirals, leading to a loss of therapeutic effect.
  • Strong Inducers (e.g., Rifampin, St. John's Wort): These agents can rapidly decrease omeprazole plasma levels and should be avoided.

Mechanism of Action

Irreversible Inactivation of the Proton Pump

The Omeprazole molecule concentrates specifically within the highly acidic environment of the stomach's parietal cells, where it is converted into its active inhibitory form, a sulfenamide. This activation is dependent on the local presence of hydrogen ions ( H^+). The active metabolite forms a stable covalent disulfide bond with specific Cysteine residues on the H^+/ K^+ ATPase enzyme (the Proton Pump), rendering it permanently non-functional. This molecular blockade of the ion-transporting enzyme directly prevents the release of hydrogen ions into the stomach lumen, leading to a profound reduction in gastric acid concentration.

Sustained Blockade Through Enzyme Turnover

Omeprazole functions as an irreversible inhibitor. The duration of the resulting acid-suppressing effect is determined by the rate at which the parietal cell can synthesize and insert entirely new Proton Pump molecules into its secretory membrane to replace the inactivated ones. This required enzyme turnover, rather than the drug's half-life in plasma, dictates the sustained physiological effect of acid blockade.

Dosage and Administration Information

Omepril (Omeprazole) is administered in a manner that ensures the delayed-release formulation remains effective. The medicine is primarily taken via the oral route, using delayed-release capsules, tablets, or oral suspension powder.

Administration and Dosage Rules

Feature Parameters
Timing in Relation to Meals Must be taken before eating, preferably in the morning.
Dosing Frequency Typically once daily (20 mg or 40 mg); Twice daily is used for H. pylori eradication and high-dose conditions.
Standard Adult Dose 20 mg once daily for duodenal ulcers or symptomatic GERD; 40 mg once daily for gastric ulcers.
High-Dose Condition Rule For daily doses exceeding 80 mg, such as for Pathological Hypersecretory Conditions, the total daily amount is administered in divided doses.

Preparation and Procedural Constraints

Delayed-release capsules or tablets must be swallowed whole. The medication should not be chewed or crushed, as this action compromises the protective enteric coating required for proper absorption.

For patients who cannot swallow the capsule whole, the contents (pellets only) may be mixed with applesauce or non-carbonated water and swallowed immediately. The pellets must remain intact and must not be crushed or chewed during this process. Pediatric dosing is determined by body weight and specific age groups. If a dose is missed, it should be taken as soon as possible, but if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not take two doses at the same time.

Recent Clinical Evidence

Omeprazole: Recent Clinical Evidence

Clinical research has focused on the role of omeprazole in the management of acid-related disorders, primarily Gastroesophageal Reflux Disease (GERD) and Helicobacter pylori eradication regimens.


Gastroesophageal Reflux Disease (GERD)

Controlled trials consistently indicate that omeprazole, a proton pump inhibitor, is associated with a resolution of heartburn and other GERD symptoms, as well as the healing of erosive esophagitis. For symptomatic GERD without visible esophageal damage, research suggests:

  • Dosage Comparison: A once-daily 20 mg dose was observed to be associated with significantly higher rates of complete heartburn resolution compared to a 10 mg dose or placebo over a four-week period.
  • Symptom Relief: Studies noted an association between omeprazole and an improvement in other symptoms of acid regurgitation, dysphagia (difficulty swallowing), and epigastric pain.
  • Maintenance Therapy: In long-term maintenance studies for GERD symptom remission, omeprazole 10 mg daily demonstrated similar symptom-free rates to certain other PPIs over 42 weeks.

Helicobacter pylori Eradication

Omeprazole is a standard component of multi-drug regimens designed to eliminate the bacterium H. pylori.

Research has explored the role of omeprazole dose and duration within triple therapy (typically omeprazole plus two antibiotics) and quadruple therapy (adding bismuth) regimens:

Regimen Feature Associated Median Eradication Rates*
Standard Triple Therapy (Omeprazole + 2 antibiotics) 86%
Triple Therapy (10 days duration) 91%
High-Dose PPI (e.g., Omeprazole 40 mg/day) in Triple Therapy 86%–88%

*Median eradication rates are based on meta-analyses of multiple trials using various antibiotic combinations and durations. Treatment success depends on antibiotic resistance patterns and patient adherence.

Frequently Asked Questions (FAQ)

Common questions about Omepril (FAQ)


Q: How quickly should I expect to feel an effect after starting Omepril?

A: Official documentation states that the acid-suppressing effect begins within approximately one hour after the first dose. However, the full, profound acid-blocking effect is generally achieved after approximately four days of consistent daily use, as the mechanism requires time to take full effect.

Q: Does Omepril start working immediately?

A: The antisecretory (acid-blocking) action begins within approximately an hour after the dose. However, official information on the drug's mechanism confirms that it takes several days of consistent dosing to achieve the full, steady-state level of acid control and maximum symptom relief.

Q: Is it better to take Omepril before or after eating?

A: Official administration instructions specify that Omepril delayed-release capsules or tablets is instructed to be taken before a meal. This timing is generally required for the medicine to work as intended on the acid-secreting cells.

Q: What are the long-term safety concerns associated with Omepril use?

A: Regulatory documents list duration-related patterns, which include an increased risk of bone fracture, Cyanocobalamin (Vitamin B-12) deficiency, and hypomagnesemia (low magnesium). The risk for fractures is noted to increase with use of a year or longer.

Q: What does the research say about stopping Omepril after long-term use?

A: Official documents note that when the medicine is discontinued, secretory activity is noted to return gradually over the course of three to five days. This return is expected, as the acid-blocking effect is determined by the creation of new stomach enzymes.

Q: What is 'rebound acid' after stopping Omepril?

A: This term describes a temporary return of acid production that may occur after stopping long-term use. Regulatory and scientific literature describes how chronic acid suppression can cause temporary changes in the body's control systems, such as elevated gastrin levels, which may contribute to this temporary increase.

Q: What is the difference between prescription and over-the-counter Omepril?

A: Over-the-counter (OTC) Omepril is available in a specific dose and is indicated for the treatment of frequent heartburn. Prescription versions are available in higher dosages and are used for a wider range of acid-related conditions, such as ulcers and erosive esophagitis, sometimes for longer durations.

Q: Why is Omepril often taken in the morning?

A: Official instructions specify taking it before a meal, preferably in the morning. This preference is generally related to the medication's mechanism, which works best when the acid-secreting pumps are active, as they are during the day, triggered by eating.

Q: Why does Omepril need to be taken consistently to work best?

A: Omepril functions as an irreversible inhibitor; it permanently disables the stomach's acid pumps. Consistent daily dosing is noted as being required because the drug's effect lasts only until the body can synthesize and insert entirely new acid pump molecules to replace the inactivated ones.

Q: Is Omepril the same as other 'acid reflux' medications I see advertised?

A: Omepril belongs to the Proton Pump Inhibitor (PPI) class, which works by blocking the final step of acid production. Other common acid medications, like H2 blockers or antacids, work through different methods, such as blocking a chemical signal or neutralizing acid directly.

Q: What is the difference between Omepril and a H2 blocker?

A: Omepril, a PPI, works by irreversibly blocking the final acid pump in the stomach's parietal cells. An H2 blocker works through a different mechanism, by blocking the histamine 2 receptor, which is a specific signal that stimulates the acid pump to start working.

Q: What happens if I forget to take Omepril one day?

A: If a dose is missed, official patient counseling information advises taking it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Taking double or extra doses is advised against.

Q: Can Omepril be taken at any time of day?

A: Official guidance states that it should be taken before a meal, preferably in the morning. However, for certain conditions requiring higher daily amounts, the total daily dose is administered in divided doses which are taken before the first and evening meals.

Q: Is it normal to feel a little dizzy when starting Omepril?

A: Dizziness is documented in official prescribing information as an Uncommon adverse reaction, meaning it has been reported in clinical experience but is not one of the most frequently occurring side effects. Common reactions often include headache and mild gastrointestinal effects.

Q: Can Omepril cause bone thinning?

A: Official prescribing information notes that long-term use and high daily dose therapy may be associated with an increased risk for osteoporosis-related fractures (hip, wrist, or spine). This risk relates to the weakening of bone density often described as 'bone thinning.'

Q: Is there a risk of kidney problems with Omepril?

A: A condition called Acute Tubulointerstitial Nephritis (TIN), which is an inflammation of the kidneys, has been observed in patients taking drugs in this class and is noted in official warnings.

Q: Are there any supplements that should not be taken with Omepril?

A: Official warnings specifically advise against concomitant use with St. John's Wort, an herbal product, as it can decrease the effectiveness of Omepril. There are no broad, restrictive lists of all other supplements in the product information.

Q: Does Omepril interact with herbal remedies?

A: Official warnings specifically advise avoiding concomitant use with the herbal product St. John's Wort because it is a strong enzyme inducer that can rapidly decrease Omepril's concentration in the body, potentially reducing its therapeutic effect.

Q: What is the recommended duration of treatment for Omepril?

A: Recommended treatment durations vary based on the specific condition it is used to address. Official documents state that short-term use for conditions like symptomatic GERD is generally up to 4 weeks, while long-term use is reserved for maintenance therapy and Pathological Hypersecretory Conditions.

Q: Do I need a prescription to get Omepril?

A: Omepril is available in both prescription and over-the-counter (OTC) forms. The OTC product is available in a specific dose to treat frequent heartburn, while higher doses and treatment for other specific conditions require a prescription.

Q: Why do some people take Omepril for a long time?

A: Omepril is indicated for the long-term treatment of certain chronic medical conditions. These include rare diseases that cause excessive acid production, known as Pathological Hypersecretory Conditions (like Zollinger-Ellison syndrome), and for the maintenance of healing of erosive esophagitis.

Q: Are there any known allergic reactions to Omepril?

A: The medicine is contraindicated (should not be used) in people with a known hypersensitivity or allergy to Omepril or other PPIs. Severe Cutaneous Adverse Reactions (SCARs), such as extensive skin reddening, blisters, or rash, are noted in official information as serious, rare effects.

Q: Can Omepril affect the absorption of other medicines?

A: Yes, official documents indicate that reducing gastric acid can affect the absorption of medicines whose effectiveness relies on an acidic stomach environment. Official documents also indicate that Omepril can impact the metabolism of certain co-administered drugs.

Q: How does Omepril affect digestion besides reducing acid?

A: Aside from reducing acid, the most common reported adverse reactions are related to the gastrointestinal system, including abdominal pain, diarrhea, and flatulence. The medication has also been associated with an increase in viable bacteria concentrations in the stomach.

Q: Are there any food restrictions while taking Omepril?

A: The primary instruction is that the medicine must be taken before a meal. There are no broad food restrictions listed, but the delayed-release formulation requires that the pellets must not be chewed or crushed, and only certain foods (like applesauce) or liquids may be used for alternative administration.

Q: Does Omepril make it harder to absorb iron?

A: Official documents state that the reduction of gastric acid has been noted to impact the body's uptake of certain substances, including iron salts, whose absorption is dependent on an acidic stomach environment.

How should Omepril be stored and disposed of?

Storage and Disposal Requirements for Omeprazole

Omeprazole delayed-release capsules and tablets must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). The medicine must be protected from moisture and light and should be kept in the original container, tightly closed.

Handling and Child Safety

It is required to keep the medication out of reach of children. If the contents of delayed-release capsules are mixed with food for administration, the dose must be swallowed immediately and not stored for later use due to stability constraints.

Disposal

Unused or expired omeprazole must be disposed of in accordance with local requirements to ensure environmental protection. General regulatory guidance advises against flushing the medicine down a toilet or pouring it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Omepril found in:

A-Z Index: